232 related articles for article (PubMed ID: 11556659)
1. ASHP therapeutic position statement on the safe use of pharmacotherapy for obesity management in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on April 23, 2001.
Am J Health Syst Pharm; 2001 Sep; 58(17):1645-55. PubMed ID: 11556659
[TBL] [Abstract][Full Text] [Related]
2. Past and present of antiobesity agents: focus on monoamine modulators.
Khorassani FE; Misher A; Garris S
Am J Health Syst Pharm; 2015 May; 72(9):697-706. PubMed ID: 25873617
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
Gadde KM; Pritham Raj Y
Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293
[TBL] [Abstract][Full Text] [Related]
4. ASHP therapeutic position statement on the identification and treatment of Helicobacter pylori-associated peptic ulcer disease in adults. Developed by the ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 11, 2000.
ASHP Commission on Therapeutics. ASHP Board of Directors
Am J Health Syst Pharm; 2001 Feb; 58(4):331-7. PubMed ID: 11225171
[TBL] [Abstract][Full Text] [Related]
5. Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice.
Gadde KM
Expert Opin Pharmacother; 2014 Apr; 15(6):809-22. PubMed ID: 24548209
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for weight loss: the cardiovascular effects of the old and new agents.
Walter CP; Bleske BE; Dorsch MP
J Clin Pharm Ther; 2014 Oct; 39(5):475-84. PubMed ID: 24924286
[TBL] [Abstract][Full Text] [Related]
7. Current and Future Medical Treatment of Obesity.
Umashanker D; Igel LI; Kumar RB; Aronne LJ
Gastrointest Endosc Clin N Am; 2017 Apr; 27(2):181-190. PubMed ID: 28292399
[TBL] [Abstract][Full Text] [Related]
8. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
9. Long-term pharmacotherapy for obesity.
Klein S
Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
[TBL] [Abstract][Full Text] [Related]
10. Recent concepts of pharmacotherapy and bariatric surgery for childhood obesity: an overview.
Gogakos A; Tzotzas TC; Krassas GE
Pediatr Endocrinol Rev; 2009 Dec; 7(2):3-14. PubMed ID: 20118889
[TBL] [Abstract][Full Text] [Related]
11. Interface between pharmacotherapy and genes in human obesity.
O'Connor A; Swick AG
Hum Hered; 2013; 75(2-4):116-26. PubMed ID: 24081227
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for Obesity.
Saunders KH; Shukla AP; Igel LI; Kumar RB; Aronne LJ
Endocrinol Metab Clin North Am; 2016 Sep; 45(3):521-38. PubMed ID: 27519128
[TBL] [Abstract][Full Text] [Related]
13. Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk.
Caterson ID; Finer N
Asia Pac J Clin Nutr; 2006; 15 Suppl():55-62. PubMed ID: 16928662
[TBL] [Abstract][Full Text] [Related]
14. Do we need anti-obesity drugs?
Hainer V; Hainerová IA
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():8-20. PubMed ID: 23280861
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for the treatment of obesity.
Sweeting AN; Hocking SL; Markovic TP
Mol Cell Endocrinol; 2015 Dec; 418 Pt 2():173-83. PubMed ID: 26360586
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy in Treatment of Obesity.
Keith JN
Gastroenterol Clin North Am; 2016 Dec; 45(4):663-672. PubMed ID: 27837780
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for the management of obesity.
Patel D
Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
[TBL] [Abstract][Full Text] [Related]
18. Current and novel approaches to the drug therapy of obesity.
Chaput JP; Tremblay A
Eur J Clin Pharmacol; 2006 Oct; 62(10):793-803. PubMed ID: 16937118
[TBL] [Abstract][Full Text] [Related]
19. Progress and challenges in anti-obesity pharmacotherapy.
Bessesen DH; Van Gaal LF
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):237-248. PubMed ID: 28919062
[TBL] [Abstract][Full Text] [Related]
20. Weight Loss Strategies for Treatment of Obesity: Lifestyle Management and Pharmacotherapy.
Kushner RF
Prog Cardiovasc Dis; 2018; 61(2):246-252. PubMed ID: 29890171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
